More fraud has risen to the surface of the Wuhan coronavirus (Covid-19) plandemic cesspool, this time in Texas.
Deepak Kaushal, director of the Southwest National Primate Research Center at the Texas Biomedical Research Institute (Texas Biomed), admitted to fabricating data in a paper he published, as well as in two grant applications he filed with the federal government, including the infamous National Institutes of Health (NIH).
The study in question was published back in 2020 and was later retracted after it was determined that Kaushal fabricated the number of weekly doses of a treatment given to macaques with Mycobacterium tuberculosis, among other skewed data.
The American Journal of Respiratory and Critical Care Medicine later published a retraction revealing that Kaushal's study "did not conform to the state experimental protocol," but that "the conclusions of the article may be correct."
In the two grant applications, Kaushal claimed to be affiliated with both the Texas primate research center and the Tulane National Primate Research Center in Louisiana. Both of these institutions are still listed on the biography page of Kaushal's website.
It turns out, however, that Kaushal had to be disciplined at the Texas center for more fraud, to which he was given "the minimal consequences," according to center president Dr. Larry Schlesinger.
"Dr. Kaushal has received internal consequences, including significant oversight of his lab," Schlesinger is quoted as saying.
"Texas Biomed is confident that this will not happen again and that Dr. Kaushal can continue to lead the Southwest National Primate Research Center capably and with integrity."
Whatever happened before Kaushal's time at the center, Schlesinger added, has nothing to do with his current work.
Were any of Pfizer's covid jab trials legitimate?
Texas Biomed is one of the companies that conducted tests on Pfizer's mRNA (messenger RNA) injections. Kaushal was involved in these tests, having authored a paper that was published in the peer-reviewed journal Nature in 2021.
The paper involved "vaccinated" and "unvaccinated" macaques that were used as test subjects in various Fauci Flu shot experiments. (Related: Pfizer also committed other fraud in other tests by classifying all adverse reactions as "not related to shots.")
Kaushal reportedly conducted the research before leaving the Tulane National Primate Research Center in Louisiana, with which he had been affiliated for all sorts of primate research involving pharmaceuticals and vaccine drugs.
"After its publication, an anonymous complaint regarding possible research misconduct was received by Tulane," a spokesperson from the Tulane group said in a statement to The Epoch Times.
"Tulane cooperated with Dr. Kaushal's current institution in their inquiry into this matter, in adherence with standards that have been established to ensure the integrity of scientific findings and the public's trust in those findings."
Ronald Desrosiers, who directed the New England Primate Research Center, says Kaushal's employer should not have retained him because his fraudulent work tarnishes the industry's reputation – not to mention all that wasted taxpayer money.
"Any scientist who knowingly and intentionally falsifies data for the purpose of scientific publication and / or receipt of government funding should not be allowed to lead a research institution," Desrosiers told Science magazine.
Kaushal has since entered into a settlement agreement to have his research fully supervised for an entire year beginning on July 22, according to the Office of Research Integrity.
Part of this agreement requires a committee of senior faculty members at Texas Biomed to provide oversight and guidance of Kaushal's work, as well as a full review of each application for government grants that he files.
"The deceit continues to build and dishonesty and fraud are the ways of the present," wrote a commenter at The Epoch Times. "I don't trust anything coming out of the NIH, anyway."
The latest news about Fauci Flu shots can be found at Vaccines.news.
Sources for this article include:
Please contact us for more information.